Jun 2026 (Q2 FY26) — Aug 6, 2026
Cryoport Q2 FY26 — Strong Revenue Growth and Positive Adjusted EBITDA Achieved
Read the full callCryoport (CYRX) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Cryoport earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 49.0 | +7.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -20.5 | +0.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -8.3 | −107.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$16.84 −1.35% · −$0.23
Performance +68.2% 1Y
1Y: $10.01 on 15 Oct 2025 → $16.84. High $18.14 (5 Oct 2026), low $7.72 (12 Mar 2026).
- Previous close
- $17.07
- 52-week range
- $7.72 – $18.14
- One year
- +57.24%
Overview
- Symbol
- CYRX
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Cryoport earnings calls (CYRX)
Financials
What the filings say
Net profit, year on year: −108% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 38 | 60 | 41 | 45 | 44 | 45 | 48 | 49 |
| Operating profit | -13 | -14 | -7 | -10 | -10 | -10 | -10 | -10 |
| Operating margin | −34.9% | −23.4% | −17.5% | −21.2% | −22.4% | −22.1% | −20.1% | −20.5% |
| Other income | 18 | -5 | 1 | -2 | 3 | 3 | 0 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Profit before tax | 4 | -19 | -7 | -12 | -7 | -7 | -9 | -8 |
| Tax rate | 7.5% | −0.2% | −3.6% | −2.3% | −2.5% | −15.2% | −1.2% | −6.5% |
| Net profit | 1 | -19 | -12 | 109 | -7 | -12 | -11 | -8 |
| EPS ($ per share) | 0.02 | — | -0.28 | 2.13 | -0.18 | — | -0.25 | -0.20 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -141 | -159 | -192 | -468 | -543 | -642 | -757 | -689 |
| Total liabilities | 18 | 10 | 170 | 471 | 483 | 469 | 302 | 262 |
| Fixed assets | 4 | 12 | 30 | 49 | 64 | 85 | 80 | 85 |
| Investments | 10 | 47 | 56 | 490 | 487 | 410 | 216 | 161 |
| Total assets | 57 | 136 | 552 | 1,113 | 1,039 | 958 | 703 | 765 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3 | -1 | -15 | 8 | -2 | -1 | -16 | -9 |
| Cash from investing | -13 | -63 | -382 | -469 | -60 | 36 | 177 | 250 |
| Cash from financing | 39 | 74 | 386 | 564 | -39 | -24 | -162 | -21 |
| Net cash flow | 22 | 10 | -10 | 102 | -103 | 10 | -1 | 205 |
| Capital expenditure | -3 | -5 | -9 | -24 | -22 | -39 | -17 | -16 |
| Free cash flow | -6 | -7 | -24 | -16 | -24 | -40 | -34 | -25 |
Insider filings
27 filings between Dec 10, 2025 and Aug 11, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$4.64M
14 sales by 5 insiders
7% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 7
- Award — granted as compensation
- 6
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| STEFANOVICH ROBERT | — | $3.09M | Jun 4, 2026 |
| ZECCHINI EDWARD J | — | $523.7K | Jun 11, 2026 |
| SHELTON JERRELL | — | $516.4K | Aug 11, 2026 |
| Mandalam Ramkumar | — | $474.0K | Jun 8, 2026 |
| Sawicki Mark W | — | $36.8K | Mar 23, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | SHELTON JERRELL President, CEO | Sale 10b5-1 plan | 28,800 | $429.4K |
| Jun 11, 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Option exercise | 33,600 | $161.3K |
| Jun 11, 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Sale | 33,600 | $486.2K |
| Jun 10, 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Option exercise | 1,400 | $6.7K |
| Jun 10, 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Sale | 1,400 | $21.3K |
| Jun 8, 2026 | Mandalam Ramkumar Director | Sale | 23,214 | $358.5K |
| Jun 5, 2026 | BADDOUR LINDA Director | Award | 10,350 | $0 |
| Jun 5, 2026 | Mandalam Ramkumar Director | Award | 10,350 | $0 |
| Jun 5, 2026 | Hariri Robert J Director | Award | 10,350 | $0 |
| Jun 5, 2026 | HANCOCK DANIEL M Director | Award | 10,350 | $0 |
| Jun 4, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sale | 169,427 | $2.76M |
| Apr 21, 2026 | SHELTON JERRELL President, CEO | Option exercise | 104,007 | $194.5K |
| Apr 6, 2026 | SHELTON JERRELL President, CEO | Option exercise | 50,000 | $93.5K |
| Mar 23, 2026 | Sawicki Mark W Chief Scientific Officer | Sale | 1,341 | $11.0K |
| Mar 23, 2026 | SHELTON JERRELL President, CEO | Sale | 2,894 | $23.7K |
| Mar 23, 2026 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $46.8K |
| Mar 23, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sale | 1,094 | $8.9K |
| Mar 16, 2026 | Sawicki Mark W Chief Scientific Officer | Sale | 3,235 | $25.9K |
| Mar 16, 2026 | SHELTON JERRELL President, CEO | Sale | 7,918 | $63.3K |
| Mar 16, 2026 | ZECCHINI EDWARD J See Remarks | Sale | 2,014 | $16.1K |
| Mar 16, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sale | 2,743 | $21.9K |
| Mar 14, 2026 | ZECCHINI EDWARD J See Remarks | Award | 21,322 | $0 |
| Mar 14, 2026 | Sawicki Mark W Chief Scientific Officer | Award | 22,845 | $0 |
| Mar 14, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Award | 27,413 | $0 |
| Mar 12, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sale | 38,700 | $300.4K |
| Mar 12, 2026 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | 87,188 | $163.0K |
| Dec 10, 2025 | Mandalam Ramkumar Director | Sale | 11,570 | $115.5K |
| Sep 11, 2025 | Hariri Robert J Director | Option exercise | 50,000 | $133.0K |
| Sep 11, 2025 | Hariri Robert J Director | Sale | 25,000 | $242.7K |
| Aug 22, 2025 | Hariri Robert J Director | Sale | 5,000 | $43.0K |
| Aug 19, 2025 | STEFANOVICH ROBERT Chief Financial Officer | Option exercise | 26,164 | $80.3K |
| Aug 19, 2025 | STEFANOVICH ROBERT Chief Financial Officer | Sale | 9,300 | $80.6K |
| Aug 13, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jul 31, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jul 24, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jul 22, 2025 | Mandalam Ramkumar Director | Sale | 40,728 | $294.9K |
| Jul 22, 2025 | Mandalam Ramkumar Director | Option exercise | 60,000 | $184.2K |
| Jul 18, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jul 8, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jun 25, 2025 | SHELTON JERRELL President, CEO | Option exercise | 25,000 | $125.0K |
| Jun 24, 2025 | SHELTON JERRELL President, CEO | Sale | 16,344 | $115.4K |
| Jun 24, 2025 | SHELTON JERRELL President, CEO | Option exercise | 16,344 | $81.7K |
| Jun 24, 2025 | Mandalam Ramkumar Director | Option exercise | 20,000 | $61.4K |
| Jun 24, 2025 | Mandalam Ramkumar Director | Sale | 13,321 | $93.4K |
| Jun 20, 2025 | SHELTON JERRELL President, CEO | Sale | 69,135 | $447.5K |
| Jun 20, 2025 | SHELTON JERRELL President, CEO | Option exercise | 69,135 | $345.7K |
| Jun 18, 2025 | SHELTON JERRELL President, CEO | Option exercise | 119,281 | $596.4K |
| Jun 18, 2025 | SHELTON JERRELL President, CEO | Sale | 119,281 | $812.5K |
| Jun 17, 2025 | SHELTON JERRELL President, CEO | Sale | 151,304 | $1.03M |
| Jun 17, 2025 | SHELTON JERRELL President, CEO | Option exercise | 50,000 | $250.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Cryoport, Inc.
Free account. Everything above stays public.
Write why you follow Cryoport, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading